Showing results (1-10 of 214) with videos related to
Sort By:
Pageof 22
Artificial Organs|May 1, 1995
Biocompatibility in hemodialysis: clinical relevance in 1995S Shaldon, K M KochKidney International. Supplement|October 1, 1992
Dialysis related amyloidosis: a disease of chronic retention and inflammation?J Floege, J Schäffer, K M Koch, et al.Artificial Organs|July 1, 1996
Bacterial challenge of NISSHO ultrafilter ETF 609: results of in vitro testingS Krautzig, G Lonnemann, S Shaldon, et al.The Journal of Laboratory and Clinical Medicine|July 1, 1988
Studies on the ability of hemodialysis membranes to induce, bind, and clear human interleukin-1G Lonnemann, K M Koch, S Shaldon, et al.Clinical Nephrology|November 1, 1995
Beta 2-microglobulin amyloidosis: why and how to look for itJ Schaeffer, G Ehlerding, J Flöge, et al.Blood Purification|January 1, 1996
Retention of cytokine-inducing substances inside high-flux dialyzersV Lufft, A Mahiout, S Shaldon, et al.British Medical Journal|July 24, 1971
Testosterone therapy for anaemia in maintenance dialysisS Shaldon, K M Koch, F Oppermann, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1988
Beta 2-microglobulin kinetics during haemofiltrationJ Floege, M Wilks, S Shaldon, et al.Lymphokine Research|January 1, 1987
Plasma interleukin-1 activity in humans undergoing hemodialysis with regenerated cellulosic membranesG Lonnemann, M Bingel, K M Koch, et al.Nephron|January 1, 1988
Plasma interleukin-1 activity during hemodialysis: the influence of dialysis membranesM Bingel, G Lonnemann, K M Koch, et al.Pageof 22